Product NDC: | 0179-1980 |
Proprietary Name: | Zolpidem Tartrate |
Non Proprietary Name: | Zolpidem Tartrate |
Active Ingredient(s): | 5 mg/1 & nbsp; Zolpidem Tartrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-1980 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA077322 |
Marketing Category: | NDA |
Start Marketing Date: | 20081001 |
Package NDC: | 0179-1980-15 |
Package Description: | 15 TABLET, COATED in 1 BOTTLE (0179-1980-15) |
NDC Code | 0179-1980-15 |
Proprietary Name | Zolpidem Tartrate |
Package Description | 15 TABLET, COATED in 1 BOTTLE (0179-1980-15) |
Product NDC | 0179-1980 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Zolpidem Tartrate |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20081001 |
Marketing Category Name | NDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | ZOLPIDEM TARTRATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE] |